0
×

Selected Tests

No tests selected yet.

آپکی صحت کا نمبر 24/7

03-111-456-789

HLA-B27 Allele Detection by PCR

Specimen Required

1 ETDA tube containing 3cc Blood

Fasting Required

Add To Cart

Purpose of the Test

To find out whether you have human leucocyte antigen B27 (HLA-B27) on the surface of your cells; to help assess whether you might have an autoimmune disorder associated with the presence of HLA-B27

When this test is required

An HLA-B27 test may be requested when a person has acute or chronic pain and inflammation in the spine, neck, chest, eyes, and/or joints, and the doctor suspects an autoimmune disorder that is associated with the presence of HLA-B27. Doctors frequently must rely on their clinical findings and the HLA-B27 test result when diagnosing ankylosing spondylitis, and other HLA-B27-related disorders, because the characteristic changes to the bones may not be detectable for several years. Under these circumstances, HLA-B27 is not diagnostic but adds additional information, increasing or decreasing the likelihood that the patient has ankylosing spondylitis. An HLA-B27 may also be ordered when someone has recurrent uveitis.

What the Test Detects

Every nucleated cell in your body has proteins protruding from the cell surface called human leucocyte antigens (HLA). These proteins are very diverse. Several thousand different types are known. Everybody has a number of different types of these proteins on each cell and together they make up an individual’s “Tissue Type”. One common HLA protein is HLA-B27. Its prevalence varies considerably across the world but it is found in…Every nucleated cell in your body has proteins protruding from the cell surface called human leucocyte antigens (HLA). These proteins are very diverse. Several thousand different types are known. Everybody has a number of different types of these proteins on each cell and together they make up an individual’s “Tissue Type”. One common HLA protein is HLA-B27. Its prevalence varies considerably across the world but it is found in about 8% of the UK population. HLA proteins are of great importance to the human immune system. They enable it to distinguish our own cells and proteins from those of bacteria, viruses and other “invaders” and so enable it to identify these invaders for attack whilst avoiding attacking its own cells. The test determines the presence or absence of HLA-B27 on the surface of a person’s white blood cells (leucocytes). Sometimes a genetic test is used but the test result is essentially the same. HLA-B27 is found in about 8% of the UK population. Its presence has been associated with several autoimmune disorders. The most common of these disorders is ankylosing spondylitis (AS). In the UK about 95% of people with AS have the HLA-B27 protein expressed on their cells (they are “HLA-B27 positive”). Other disorders that have an association with the presence of HLA-B27 include juvenile rheumatoid arthritis (JRA), reactive arthritis (including Reiter syndrome), and isolated acute anterior uveitis. HLA-B27 is also more common in people with spondylitis associated with inflammatory bowel disease and psoriatic arthritis. HLA-B27 has not been established as a cause of these disorders but HLA-B27 positivity is more common in people with these disorders than in people without them. However, it is important to realise that HLA-B27 is very common and so most people who are HLA-B27 positive do not have any of these disorders. See MoreSee Less

Preparation for the Test

None

Sample Requirements

A blood sample taken from a vein in your arm

Additional Notes

Although the diseases associated with HLA-B27 occur more frequently in men, women can also be affected. The signs and symptoms of the diseases associated with HLA-B27 are often milder in women than in men.With new genetic testing methods, it is now possible to separate HLA-B27 into subtypes. Over 100 different subtypes of the HLA-B27 gene exist. The most common in the U.K. are HLA-B27*05, HLA-B27*04 and HLA B27*02. How the presence of these specific subtypes affects the likelihood of developing an autoimmune disease is not yet known.